NCT03899818View on ClinicalTrials.gov

Drug Eluting Balloon Efficacy for Small Coronary Vessel Disease Treatment

NACompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

January 1, 2014

Primary Completion Date

April 25, 2018

Study Completion Date

February 28, 2019

Conditions
Cardiovascular Diseases
Interventions
DEVICE

drug-eluting balloon

Patients will be randomized to drug-eluting balloon (DEB) or standard therapy with second generation drug-eluting stent (DES)

DEVICE

drug-eluting stent

Patients will be randomized to drug-eluting balloon (DEB) or standard therapy with second generation drug-eluting stent (DES).

All Listed Sponsors
lead

Fatebenefratelli and Ophthalmic Hospital

OTHER

NCT03899818 - Drug Eluting Balloon Efficacy for Small Coronary Vessel Disease Treatment | Biotech Hunter | Biotech Hunter